Determination of the Proteomic Response to Lapatinib Treatment using a comprehensive and reproducible ion-current-based proteomics strategy

Lapatinib, a small molecule tyrosine kinase inhibitor is currently used in the treatment of HER2-positive breast cancer. The aim of this study was to further understanding of lapatinib response for the development of novel treatment lapatinib-focussed treatment strategies. HER2-overexpressing SKBR3...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Proteom Genom Res
Prif Awduron: O’Connell, Kathleen, Li, Jun, Engler, Frank, Hennessy, Kim, O’Neill, Fiona, Straubinger, Robert M., Qu, Jun, O’Connor, Robert
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2013
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5642974/
https://ncbi.nlm.nih.gov/pubmed/29046878
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14302/issn.2326-0793.jpgr-13-257
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg